Nerve Repair and Regeneration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

The nervous system is made up of delicate and complex structures such as the spinal cord, brain, and peripheral nerves. They are predisposed to a variety of diseases, including Alzheimer's disease, Amyotrophic lateral sclerosis, Parkinson's disease, multiple system atrophy, and multiple sclerosis. The repair and regeneration of nerve cells or tissues are referred to as nerve repair and regeneration. It typically includes mechanisms such as the formation of new glia, neurons, axons, myelin, and synapses. Nerve regeneration is divided into two parts: the peripheral nervous system (PNS) and the central nervous system (CNS) (CNS). The CNS is made up of the brain and spinal cord, while the PNS is made up of spinal and cranial nerves as well as their associated ganglia. The PNS has an inherent ability to regenerate, whereas the CNS is incapable of repair and regeneration.

Nerve Repair and Regeneration Market is primarily due to the increasing prevalence of traumatic brain injuries (TBIs) as well as various neurological diseases such as acute spinal cord injury, ataxia, and Alzheimer's disease. Furthermore, the surge in support from government organizations for research on nervous system disorders is expected to drive domain growth during the forecast period.

The key factors driving the market are rising cases of the Nerve Repair and Regeneration Market and a strong product pipeline by major companies. Improved treatment efficiency for neurological disorders as a result of technological advancements is also expected to contribute to market growth.

Nerve repair, also known as neuroregeneration, is defined as the repair or regrowth of nervous tissues and cells through the generation of new neurons, axons, synapses, and myelin.

Nerve Repair and Regeneration Market, neuromodulators, and biomaterial devices are among the products available for nerve repair and regeneration. These devices are used to treat traumatic or neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy. Because the brain, spinal cord, and peripheral nerves are fragile and easily damaged, they can interfere with the brain's ability to communicate with muscles and organs. These damages are repaired with nerve repair and regeneration products.

Key Players

AxoGen, Boston Scientific, Liva Nova, Integra Life Sciences, Medtronic, Abbott Laboratories, Stryker, Nevro, Polyganics, Neuvectra, OrthoMed S.A.S, St. Jude Medical, Cyberonics Inc., and others are among the key players in the nerve repair and regeneration market.

x